Whilst dizziness is not among the most commonly reported side effects, some patients experience light-headedness, particularly when starting treatment or during dose escalation
Regular monitoring allows providers to adjust treatment strategies when appropriate
Injection Site Reactions: As with any SubQ injection, minor redness, swelling, or irritation may occur at the injection site
We will assess your medical history, allergies, and current health status to determine if glutathione therapy is suitable for you
At Week 56, treatment with SAXENDA resulted in statistically significant reduction in BMI SDS from baseline compared to placebo
Patients should start with the gentlest effective optiontypically PEG 3350and escalate only if necessary, always under healthcare provider guidance